Blood Thinner Lawsuits Examine Study That Finds Anticoagulants Carry High Bleeding Risk

   

Blood Thinner Lawsuits Allege Patients Taking Anti-Clotting Medications Suffer Uncontrollable Bleeding, Brain Bleed, Stroke, Blood Clots, And Other Injuries.

blood-thinner-lawsuit-blood-thinner-lawyerBlood Thinner Lawsuits: As filings continue of blood thinner lawsuits alleging the medications cause internal bleeding injuries, a recent study has found anticoagulants increase the risk of subdural hematoma (a bleed within the skull, but outside the brain). Bleeding side-effects lawsuits claim patients suffer hematoma, severe hemorrhages, gastrointestinal bleeding, stroke, and other internal bleeding injuries after taking blood thinner medications.

Southern Med Law continues to field questions from men and women who have suffered serious bleeding episodes allegedly from using such blood thinners as warfarin, Xarelto, Pradaxa and Eliquis. “Patients who have been harmed by anticoagulant medications may be entitled to seek compensation for their injuries,” says Dr. François Blaudeau, attorney and founder of Southern Med Law.

The Firm is offering no-obligation reviews to those who have been harmed by blood thinners. To speak to one of the firm’s Blood Thinner attorneys, please call 205-547-5525 or visit www.southernmedlaw.com for more information.

The study involved researchers from the Odense University Hospital and the University of Southern Denmark who used data from 10,010 patients, ages 20 to 89 years, with a first-ever subdural hematoma diagnosis from 2000 to 2015. The patients were matched with a control group of 400,380 individuals from the general population. Among the patients with subdural hematoma, 47 percent were taking antithrombotic medications. These medications include anticoagulants and antiplatelets, both of which are prescribed to prevent the formation and growth of blood clots. Researchers found low-dose aspirin was associated with a small risk of subdural hematoma. Clopidogrel (brand name Plavix) and a direct oral anticoagulant were associated with a moderate risk of subdural hematoma. The use of a vitamin K antagonist, such as warfarin, was associated with a higher risk of subdural hematoma. The study also showed antithrombotic drug use increased in the general population from 2000 to 2015, as did the overall subdural hematoma incidence rate. The study was published February 28 in the Journal of the American Medical Association.
[jamanetwork.com/journals/jama/article-abstract/2605799]

Blood thinners, also known as anticoagulants, are medications used to treat blood clots and to reduce the risk of stroke. Among the most popular blood thinners are Xarelto, Pradaxa and Eliquis, and warfarin (Jantoven, Coumadin). Warfarin is the oldest drug on the market, having received approval from the U.S. Food and Drug Administration (FDA) in 1954. Pradaxa (FDA approved in 2010), Xarelto (2011), and Eliquis (2012) are part of a class of drugs called New Oral Anticoagulants. The newer blood thinners have been promoted as being more effective and more convenient to use than warfarin. For instance, the new blood thinners do not require routine blood monitoring as does warfarin. However, Eliquis and Xarelto do not have FDA-approved antidotes to reverse their blood-thinning effects. Warfarin uses vitamin K as a reversal agent. In October 2015, the FDA approved Praxbind for use in patients who are taking Pradaxa during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.
[fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm467300.htm]

Blood thinner lawsuits are being filed in state and federal courts nationwide on behalf of patients and their survivors alleging that warfarin, Pradaxa, Xarelto, Eliquis cause gastrointestinal bleeding, brain bleeds, blood clots, heart attacks and strokes. Federal Xarelto lawsuits are consolidated in the U.S. District Court, Eastern District of Louisiana and state Xarelto complaints are centralized in a mass tort in Pennsylvania’s Philadelphia Court of Common Pleas. All federal Eliquis lawsuits are consolidated in the U.S. District Court, Southern District of New York. In 2014, Boehringer Ingelheim, which manufactures Pradaxa, announced that it would pay $650 million to settle 4,000 lawsuits alleging Pradaxa causes a high rate of heart attacks and uncontrollable bleeding.

About Southern Med Law And Filing A Blood Thinner Bleeding Lawsuit

Led by Dr. François Blaudeau, Southern Med Law has worked hard to develop a strong reputation for aggressively and effectively advocating for people who have been injured by dangerous and defective drugs. If you or a loved one experienced life-threatening bleeding complications from blood thinners, please contact the Firm today to learn more about your legal rights. You can arrange for a free, no-obligation warfarin, Pradaxa, Xarelto and Eliquis lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

This entry was posted in Southern Med Law | Article. Bookmark the permalink.